{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:51:02Z","timestamp":1792245062997,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ghir.2021.101391","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T12:33:36Z","timestamp":1619786016000},"page":"101391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The association between treatment and systemic inflammation in acromegaly"],"prefix":"10.1016","volume":"57-58","author":[{"given":"T.L.C.","family":"Wolters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.C.C.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pinzariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.T.P.","family":"Hijmans-Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hoischen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.A.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.J.","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.T.","family":"Netea-Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ghir.2021.101391_bb0005","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2021.101391_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ghir.2021.101391_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/JME-17-0062","article-title":"IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK","volume":"59","author":"Wolters","year":"2017","journal-title":"J. Mol. Endocrinol."},{"issue":"13\u201314","key":"10.1016\/j.ghir.2021.101391_bb0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/pmic.201300318","article-title":"Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes","volume":"14","author":"Spaziani","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.ghir.2021.101391_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000452913","article-title":"The Somatotrope growth hormone-releasing hormone\/growth hormone\/insulin-like growth Factor-1 Axis in Immunoregulation and Immunosenescence","volume":"48","author":"Bodart","year":"2017","journal-title":"Front. Horm. Res."},{"issue":"5","key":"10.1016\/j.ghir.2021.101391_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11102-014-0621-6","article-title":"Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly","volume":"18","author":"Ozkan","year":"2014","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.ghir.2021.101391_bb0035","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1540-8175.2010.01179.x","article-title":"Evaluation of the impact of treatment on endothelial function and cardiac performance in acromegaly","volume":"27","author":"Akgul","year":"2010","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.ghir.2021.101391_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101391_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-018-0911-5","article-title":"Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis","author":"Parolin","year":"2018","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.ghir.2021.101391_bb0050","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2021.101391_bb0055","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2021.101391_bb0060","doi-asserted-by":"crossref","DOI":"10.1530\/EC-19-0430","article-title":"Persistent inflammation and endothelial dysfunction in patients with treated acromegaly","author":"Wolters","year":"2019","journal-title":"Endocr. connect."},{"issue":"7","key":"10.1016\/j.ghir.2021.101391_bb0065","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9372","key":"10.1016\/j.ghir.2021.101391_bb0070","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ghir.2021.101391_bb0075","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/IAI.69.3.1477-1482.2001","article-title":"Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages","volume":"69","author":"Hirschfeld","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ghir.2021.101391_bb0080","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1128\/IAI.73.11.7458-7464.2005","article-title":"Differential cytokine production and toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae","volume":"73","author":"van der Graaf","year":"2005","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.ghir.2021.101391_bb0085","first-page":"626","article-title":"Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups \u201cAtherosclerosis & Vascular Biology\u201d and \u201cthrombosis\u201d","volume":"116","author":"Weber","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ghir.2021.101391_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ghir.2021.101391_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ghir.2021.101391_bb0100","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ghir.2021.101391_bb0105","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","author":"Zhu","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ghir.2021.101391_bb0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ghir.2021.101391_bb0115","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","article-title":"Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans","volume":"40","author":"Thijssen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ghir.2021.101391_bb0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","article-title":"European society of hypertension working group on vascular, function, A. European Network for noninvasive investigation of large, expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity","volume":"30","author":"Van Bortel","year":"2012","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.ghir.2021.101391_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/HYPERTENSIONAHA.107.101014","article-title":"Importance of measuring the time course of flow-mediated dilatation in humans","volume":"51","author":"Black","year":"2008","journal-title":"Hypertension"},{"issue":"34","key":"10.1016\/j.ghir.2021.101391_bb0130","article-title":"Intima Media Thickness, Pulse Wave Velocity, and Flow Mediated Dilation","volume":"12","author":"Bruno","year":"2014","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.ghir.2021.101391_bb0135","doi-asserted-by":"crossref","first-page":"531389","DOI":"10.1155\/2014\/531389","article-title":"Comparison of semi-automated and manual measurements of carotid intima-media thickening","volume":"2014","author":"Mac Ananey","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ghir.2021.101391_bb0140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fimmu.2019.00944","article-title":"Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype","volume":"10","author":"Min","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ghir.2021.101391_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","article-title":"Nonclassical monocytes in health and disease","volume":"37","author":"Narasimhan","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ghir.2021.101391_bb0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2265.2012.04414.x","article-title":"GH levels and insulin sensitivity are differently associated with biomarkers of cardiovascular disease in active acromegaly","volume":"77","author":"Boero","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2021.101391_bb0155","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2265.2007.02986.x","article-title":"Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency","volume":"67","author":"Andreassen","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101391_bb0160","series-title":"IGF-1 Levels across the Spectrum of Normal to Elevated in Acromegaly: Relationship to Insulin Sensitivity, Markers of Cardiovascular Risk and Body Composition, Pituitary","author":"Reid","year":"2015"},{"issue":"4","key":"10.1016\/j.ghir.2021.101391_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4158\/EP.13.4.363","article-title":"Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly","volume":"13","author":"Vilar","year":"2007","journal-title":"Endocrine practice\u202f: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"issue":"5","key":"10.1016\/j.ghir.2021.101391_bb0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/cen.12356","article-title":"Three noninvasive methods in the evaluation of subclinical cardiovascular disease in patients with acromegaly: epicardial fat thickness, aortic stiffness and serum cell adhesion molecules","volume":"80","author":"Topaloglu","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2021.101391_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.matbio.2015.01.015","article-title":"Metalloproteinases promote plaque rupture and myocardial infarction: a persuasive concept waiting for clinical translation","volume":"44-46","author":"Newby","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ghir.2021.101391_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2015.05.007","article-title":"Therapeutic uses of somatostatin and its analogues: current view and potential applications","volume":"152","author":"Rai","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2021.101391_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2006.10.007","article-title":"Inhibitory effect of pasireotide and octreotide on lymphocyte activation","volume":"182","author":"Lattuada","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.ghir.2021.101391_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03345700","article-title":"Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells","volume":"32","author":"ter Veld","year":"2009","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.ghir.2021.101391_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2003.10.013","article-title":"Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity","volume":"173","author":"Kobayashi","year":"2004","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ghir.2021.101391_bb0200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11102-016-0710-9","article-title":"Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors","volume":"19","author":"Yaron","year":"2016","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ghir.2021.101391_bb0205","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1210\/jc.2002-021746","article-title":"The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly","volume":"88","author":"Smith","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101391_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-7120-12-34","article-title":"Intima media thickness, pulse wave velocity, and flow mediated dilation","volume":"12","author":"Bruno","year":"2014","journal-title":"Cardiovasc. Ultrasound"},{"issue":"5","key":"10.1016\/j.ghir.2021.101391_bb0215","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1507\/endocrj.K07E-125","article-title":"Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery","volume":"55","author":"Sakai","year":"2008","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.ghir.2021.101391_bb0220","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jc.2012-3072","article-title":"A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy","volume":"98","author":"Annamalai","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ghir.2021.101391_bb0225","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.CIR.0000030720.29247.9F","article-title":"Cardiovascular disease and insulin-like growth factor I","volume":"106","author":"Frystyk","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2021.101391_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2019.01.002","article-title":"IGF-1 and cardiovascular disease","volume":"45","author":"Higashi","year":"2019","journal-title":"Growth horm. IGF Res."},{"issue":"2","key":"10.1016\/j.ghir.2021.101391_bb0235","first-page":"111","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency","volume":"133","author":"Sesmilo","year":"2000","journal-title":"A Randomized, Control. Clin. Trial, Ann. Int. Med."},{"issue":"6","key":"10.1016\/j.ghir.2021.101391_bb0240","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4158\/EP.12.6.682","article-title":"Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution","volume":"12","author":"Burger","year":"2006","journal-title":"Endocrine practice\u202f: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:18Z","timestamp":1761087138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":48,"alternative-id":["S1096637421000149"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101391","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between treatment and systemic inflammation in acromegaly","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101391"}}